FDA
-
-
-
-
-
-
-
22nd Century Group Reports First Quarter 2026 Financial Results
-
-
-
-
-
-
-
22nd Century Advances Reduced Nicotine Product to Target Approximately Half of the ~$82 Billion U.S. Cigarette Market with 100mm VLN® Product Initiative
-
-
-
-
-
-
-
22nd Century Group Preliminarily Reports Fourth Quarter and Full Year 2025 Financial Results
-
-
-
-
-
-
-
22nd Century Group Reports Third Quarter 2025 Financial Results
-
-
-
-
-
-
-
22nd Century secures $9.5 million from insurance settlement
-
-
-
-
-
-
-
22nd Century Group Reports Second Quarter 2025 Financial Results
-
-
-
-
-
-
-
22nd Century expands VLN cigarette partnerships amid FDA nicotine rule
-
325,889 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

